Our Solutions   Prega End Kit Tablets

Prega End Kit Tablets

Prega End Kit Tablets

*To be consumed as directed by physician.

Therapies:

Women Care

Composition:

Mifepristone 200 mg (1 Tablet) + Misoprostol 200 mcg (4 Tablets)

About Prega End Kit Tablets

PregaEnd Kit contains Mifepristone 200 mg and Misoprostol 200 mcg, a combination medicine used for the medical termination of an early intrauterine pregnancy under the supervision of a qualified healthcare professional. It is generally used up to 70 days (10 weeks) from the first day of the last menstrual period, as advised by a doctor. Mifepristone blocks the action of progesterone, a hormone essential for maintaining pregnancy, while Misoprostol stimulates uterine contractions, helping expel the pregnancy tissue. Proper medical evaluation and follow-up are essential to ensure the treatment is safe and complete.

Prega End Kit Tablets

*To be consumed as directed by physician.


Usage Instructions

  • PregaEnd Kit should only be used under the guidance of a qualified healthcare professional.
  • Treatment typically begins with Mifepristone 200 mg, followed 36–48 hours later by Misoprostol 200 mcg, exactly as instructed by your doctor.
  • Follow the prescribed dosage and schedule carefully.
  • Do not skip doses or alter the timing without medical advice.
  • A follow-up visit, which may include an ultrasound or clinical examination, is recommended to confirm that the pregnancy has been completely terminated.

    • Benefits and Use

  • PregaEnd Kit is indicated for the medical termination of an early intrauterine pregnancy under medical supervision.
  • The combination works by stopping the hormonal support needed to continue the pregnancy and stimulating uterine contractions to complete the abortion process.
  • When used appropriately under a doctor's supervision, it provides a non-surgical option for early pregnancy termination and helps avoid the need for invasive procedures in many cases.

    • Safety Information

  • Medical Supervision Required:
  • This medicine should be used only under the supervision of a qualified healthcare professional.
  • Pregnancy:
  • This medicine is intended only for medical termination of an early confirmed intrauterine pregnancy. It should not be used if continuation of pregnancy is intended, as it may cause serious harm to the fetus.
  • Ectopic Pregnancy:
  • Do not use if an ectopic (outside the uterus) pregnancy is suspected or confirmed, as the medicine is ineffective and may delay life-saving treatment.
  • Breastfeeding:
  • Consult your doctor regarding breastfeeding after treatment, as the medicines may pass into breast milk.
  • Liver & Kidney Disorders:
  • Avoid use in severe liver disease and use with caution in severe kidney disease, only under medical supervision.
  • Common Side Effects:
  • Abdominal cramps, uterine contractions, vaginal bleeding, nausea, vomiting, diarrhea, and heavy menstrual-like bleeding.
  • Expected Effects:
  • Vaginal bleeding and cramping are expected and may continue for 1–2 weeks.
  • Seek Immediate Medical Attention.
  • if you experience very heavy bleeding (such as soaking two or more large sanitary pads per hour for two consecutive hours), severe or persistent abdominal pain, fainting, fever lasting more than 24 hours after Misoprostol, foul-smelling vaginal discharge, severe one-sided abdominal pain, or signs of an allergic reaction.
  • Avoid strenuous physical activity during the abortion process.
  • The medicine does not affect long-term fertility, and appropriate contraception should be discussed with your healthcare provider if future pregnancy is not desired.

    • Ingredients

    Mifepristone 200 mg + Misoprostol 200 mcg

    How to Use

  • Take the medicines exactly as directed by your healthcare provider.
  • Swallow the Mifepristone tablet whole with water, preferably with or after food.
  • Misoprostol should be taken 36–48 hours later using the route recommended by your doctor.
  • Rest after taking Misoprostol, as cramping and vaginal bleeding usually begin during this time.
  • Use sanitary pads to monitor bleeding, and attend all scheduled follow-up appointments.
  • Do not self-medicate or use the kit without medical supervision.

    • Storage Information

    Store below 30°C in a cool, dry place, protected from heat, moisture, and direct sunlight.